HPV-associated Head and Neck Cancer: A Virus-related Cancer Epidemic – A Review of Epidemiology, Biology, Virus Detection and Issues in Management
By S. Marur, G. D’Souza, W. Westra, A. Forastiere. The Lancet Oncology, 2010
1,776 citations recorded by the source corpus.
Summary A rise in the annual incidence of oropharynx squamous cell cancer, specifically the lingual and palatine tonsils, in white men under the age of 50, non-smokers and non-alcoholics, has been observed over the past decade. This entity is associated with human papilloma virus-16 infection and the risk factors include an increased number of oral and vaginal sex partners at a younger age. The biology of HPV-related oropharynx cancer is distinct with p53 degradation, Rb pathway inactivation, and p16 upregulation. This is in contrast to tobacco related oropharynx cancer which is characterized by p53 mutation and downregulation of p16. The optimal method to detect virus in tumor is controversial and both in situ hybridization and PCR are commonly used; p16 immunohistochemistry may serve as a potential surrogate marker. HPV-related oropharynx cancer appears to be more responsive to chemotherapy and radiation than HPV negative orpharynx cancer. HPV-16 is a prognostic marker for improved overall survival and disease-free survival but has not yet been shown to be a predictive marker. Investigators continue to explore unanswered questions regarding the natural history of oral HPV infection, why the increase dominates in men, the potential of HPV vaccines for primary prevention, developing a commercially available accurate method to detect the virus in tumor, and treatment strategies that reduce toxicity without compromising survival. The goal of this review is to highlight our current understanding of the epidemiology, biology, detection, as well as current management and unresolved issues of HPV-related oropharyngeal HNSCC.
Subfields: Epidemiology, Otorhinolaryngology, Surgery
View Paper: https://www.semanticscholar.org/paper/0a0c117c4918539b69a9e3a840673ffbcd3d437c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Otorhinolaryngology
In Surgery
Citations in the corpus
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. (2016, background): “HPV Testing There is a distinct biology and molecular phenotype among HPV-positive OPSCCs when compared with HPV-negative HNSCCs (Table 1).(11,12) It is critical to understand the HPV types and their role in carcinogenesis.”
- Worldwide burden of cancer attributable to HPV by site, country and HPV type (2017, background): “HPV-attributable head and neck cancer is mainly represented by oropharyngeal cancer for which consistent evidence suggests that two main types exist: one is driven by HPV and the other by tobacco and alcohol use.(16,17) The fraction of oropharyngeal cancer related to HPV has been increasing over the”
- Global cancer statistics (2011, background): “in the United States and in some countries in Europe,(139-143) which is hypothesized to be in part due to changes in oral sexual behavior.(130,144)”
- PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. (2013, background): “Although these tumors frequently have aggressive histopathological features (2), the presence of HPV DNA is a favorable prognostic factor with regard to recurrence and survival (3-5).”